Frequency Therapeutics Total Liabilities

Frequency Therapeutics (FREQ) currently reports a total liabilities of $64M as of March 2026. That compares with $63M in the prior-year period — up 1.2% year over year. Use the charts on this page to explore Frequency Therapeutics's total liabilities history and peer comparisons.

Frequency Therapeutics's total liabilities increased from $63M to $64M — a 1.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Frequency Therapeutics reported $64M in total liabilities as of March 2026. That compares with $63M in the prior-year period — up 1.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Frequency Therapeutics, and consider following FREQ for alerts when major investors trade the stock.

Frequency Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $64M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FREQ with unrelated industries.